AU2006209245A1 - Phenyl-substituted pyrrolidones - Google Patents

Phenyl-substituted pyrrolidones Download PDF

Info

Publication number
AU2006209245A1
AU2006209245A1 AU2006209245A AU2006209245A AU2006209245A1 AU 2006209245 A1 AU2006209245 A1 AU 2006209245A1 AU 2006209245 A AU2006209245 A AU 2006209245A AU 2006209245 A AU2006209245 A AU 2006209245A AU 2006209245 A1 AU2006209245 A1 AU 2006209245A1
Authority
AU
Australia
Prior art keywords
substituted
unsubstituted
hiv
alkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006209245A
Other languages
English (en)
Inventor
Beth M. Anaclerio
Ha-Soon Choi
David A. Ellis
Xiaohui He
Yun He
Thomas Marsilje
Truc N. Nguyen
Zhicheng Wang
Baogen Wu
Kunyong Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IRM LLC
Original Assignee
IRM LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IRM LLC filed Critical IRM LLC
Publication of AU2006209245A1 publication Critical patent/AU2006209245A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2006209245A 2005-01-28 2006-01-30 Phenyl-substituted pyrrolidones Abandoned AU2006209245A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64802705P 2005-01-28 2005-01-28
US60/648,027 2005-01-28
PCT/US2006/003217 WO2006081554A2 (en) 2005-01-28 2006-01-30 Phenyl-substituted pyrrolidones

Publications (1)

Publication Number Publication Date
AU2006209245A1 true AU2006209245A1 (en) 2006-08-03

Family

ID=36741146

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006209245A Abandoned AU2006209245A1 (en) 2005-01-28 2006-01-30 Phenyl-substituted pyrrolidones

Country Status (11)

Country Link
US (1) US20080287516A1 (enExample)
EP (1) EP1841425A4 (enExample)
JP (1) JP2008528624A (enExample)
KR (2) KR100896889B1 (enExample)
CN (1) CN101115481A (enExample)
AU (1) AU2006209245A1 (enExample)
BR (1) BRPI0606123A2 (enExample)
CA (1) CA2594915A1 (enExample)
MX (1) MX2007009137A (enExample)
RU (1) RU2371433C2 (enExample)
WO (1) WO2006081554A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003078448A1 (en) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
MX2007008974A (es) * 2005-01-28 2007-09-18 Irm Llc Sintesis de aril-pirrolidonas.
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
WO2006084033A1 (en) 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
JP5164510B2 (ja) * 2006-10-06 2013-03-21 日本曹達株式会社 含窒素複素環化合物および有害生物防除剤
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
CN102014897B (zh) 2008-04-21 2015-08-05 西格纳姆生物科学公司 化合物、组合物和其制备方法
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
CN101747253B (zh) * 2008-12-02 2013-01-16 中国人民解放军军事医学科学院毒物药物研究所 三取代的手性内酰胺类衍生物及其制备方法和用途
WO2010126626A2 (en) 2009-05-01 2010-11-04 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
GB2497476B (en) * 2010-09-06 2018-01-10 Guangzhou Inst Biomed & Health Amide Compounds
CN101979378B (zh) * 2010-10-13 2012-06-27 中国科学院上海有机化学研究所 一种手性γ-内酰胺化合物的合成方法
ES2776199T3 (es) 2013-03-15 2020-07-29 Aerie Pharmaceuticals Inc Conjugados de compuestos de isoquinolina y prostaglandinas
WO2018045091A1 (en) 2016-08-31 2018-03-08 Aerie Pharmaceuticals, Inc. Ophthalmic compositions
CA3057872A1 (en) * 2017-03-31 2018-10-04 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
WO2019046467A1 (en) * 2017-08-29 2019-03-07 Rutgers, The State University Of New Jersey INDAZOLES THERAPEUTIC
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU797219A1 (ru) * 1979-05-08 1995-07-25 Ленинградский государственный педагогический институт им.А.И.Герцена N-карбамоилметил-4-фенил-2-пирролидон, обладающий гипотензивной активностью
TW448172B (en) * 1996-03-08 2001-08-01 Pharmacia & Upjohn Co Llc Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
AU2003285952A1 (en) * 2002-10-21 2004-05-13 Irm Llc Pyrrolidones with anti-hiv activity

Also Published As

Publication number Publication date
RU2007132259A (ru) 2009-03-10
MX2007009137A (es) 2007-09-12
EP1841425A2 (en) 2007-10-10
RU2371433C2 (ru) 2009-10-27
JP2008528624A (ja) 2008-07-31
KR20070103404A (ko) 2007-10-23
BRPI0606123A2 (pt) 2009-06-02
WO2006081554A3 (en) 2006-12-14
EP1841425A4 (en) 2009-02-18
CN101115481A (zh) 2008-01-30
KR20090028846A (ko) 2009-03-19
US20080287516A1 (en) 2008-11-20
KR100896889B1 (ko) 2009-05-14
WO2006081554A2 (en) 2006-08-03
CA2594915A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
US7601742B2 (en) Pyrrolidones with anti-HIV activity
KR100896889B1 (ko) 페닐-치환 피롤리돈
US20040152755A1 (en) Oxindoles with anti-HIV activity
Baraldi et al. Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor
US9382286B2 (en) Treatment of EBV and KHSV infection and associated abnormal cellular proliferation
He et al. Design, synthesis and biological evaluation of 3-substituted 2, 5-dimethyl-N-(3-(1H-tetrazol-5-yl) phenyl) pyrroles as novel potential HIV-1 gp41 inhibitors
BR112021000395A2 (pt) Compostos imunomoduladores diméricos contra mecanismos baseados em cereblon
ZA200505184B (en) Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
KR100890696B1 (ko) 아릴 피롤리돈의 합성
US7019141B2 (en) Quinolones with anti-HIV activity
PT2069303E (pt) Inibidores de protease antiviral
US20180057465A1 (en) Inhibitors of Necroptosis
WO2023098831A1 (zh) 靶向蛋白酶降解(ted)平台
CN101309911A (zh) Hiv-1蛋白酶抑制剂及其制备方法和使用方法
CN118119623A (zh) 靶向蛋白酶降解(ted)平台
US5574040A (en) Pyrimidine compounds and methods of use to derivatize neighboring lysine residues in proteins under physiologic conditions
CN112724148B (zh) 一种咪唑并哒嗪类化合物及修饰后的双亲功能分子及其应用
EP4731611A1 (en) Targeted degraders of hiv-1 nef for the treatment of hiv disease
Klimkait et al. Oral Session I-Retrovirus Infections I
JPS62228019A (ja) 抗腫瘍剤

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted